Ellume Ltd (Ellume), a subsidiary of Hough Pharma Pty Ltd, is a health technology company that specializes in the development, manufacturing, and commercialization of digitally enabled diagnostic products. Its main activities focus on creating innovative diagnostic solutions for infectious diseases, with a focus on speed, accuracy, and affordability. The company's major products include a suite of disposable test cartridges that measure, analyze, and transmit results, utilizing a patented detection method that employs unique fluorescent nanoparticles and a sophisticated reader system. Ellume's products are designed for use by healthcare professionals and consumers alike, with applications ranging from point-of-care diagnostics to higher-throughput laboratories. The company offers medical diagnostic products to healthcare markets. Ellume is headquartered in East Brisbane, Queensland, Australia.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Ellume Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- Ellume Ltd Company Overview
- Ellume Ltd Company Snapshot
- Ellume Ltd Pipeline Products and Ongoing Clinical Trials Overview
- Ellume Ltd - Pipeline Analysis Overview
- Ellume Ltd - Key Facts
- Ellume Ltd - Major Products and Services
- Ellume Ltd Pipeline Products by Development Stage
- Ellume Ltd Pipeline Products Overview
- Ellume Respirio Flu Test
- Ellume Respirio Flu Test Product Overview
- ellume.lab - Influenza A+B / RSV
- ellume.lab - Influenza A+B / RSV Product Overview
- ellume·lab
- ellume·lab Product Overview
- ESP-Based Diagnostic Test - Chlamydia
- ESP-Based Diagnostic Test - Chlamydia Product Overview
- ESP-Based Diagnostic Test - Gonorrhoea
- ESP-Based Diagnostic Test - Gonorrhoea Product Overview
- ESP-Based Diagnostic Test - Group A Streptococci
- ESP-Based Diagnostic Test - Group A Streptococci Product Overview
- ESP-Based Diagnostic Test - Malaria
- ESP-Based Diagnostic Test - Malaria Product Overview
- ESP-Based Diagnostic Test - Pregnancy
- ESP-Based Diagnostic Test - Pregnancy Product Overview
- Point of Care Flu-COVID Combination Diagnostic Test
- Point of Care Flu-COVID Combination Diagnostic Test Product Overview
- Smart Phone Enabled Device
- Smart Phone Enabled Device Product Overview
- Ellume Ltd - Key Competitors
- Ellume Ltd - Key Employees
- Ellume Ltd - Locations And Subsidiaries
- Head Office
- Recent Developments
- Ellume Ltd, Recent Developments
- Jul 14, 2022: Ellume COVID-19 Home Test now available through covid.gov/tests for blind and low-vision people
- Dec 13, 2021: Ellume COVID-19 Home Test to allow users to send results directly to healthcare providers
- Dec 03, 2021: Emerging omicron variant reinforces the role of rapid antigen testing
- Nov 10, 2021: Ellume recalls COVID-19 home test for potential false positive SARS-CoV-2 test results
- Oct 08, 2021: Coronavirus (COVID-19) update: October 8, 2021
- Oct 06, 2021: Ellume recalls 200,000 COVID-19 test kits over false positives
- Oct 05, 2021: Potential for false positive results with certain lots of Ellume COVID-19 home tests due to a manufacturing issue: FDA safety communication
- May 10, 2021: Ellume establishes flagship U.S. manufacturing facility in Maryland
- Mar 10, 2021: Ellume and Cambridge Consultants collaborate on Core Technology behind Ellume’s Rapid Antigen COVID-19 Test
- Feb 01, 2021: Ellume announces $231.8 million agreement with the U.S. government
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- Ellume Ltd Pipeline Products and Ongoing Clinical Trials Overview
- Ellume Ltd Pipeline Products by Equipment Type
- Ellume Ltd Pipeline Products by Indication
- Ellume Ltd, Key Facts
- Ellume Ltd, Major Products and Services
- Ellume Ltd Number of Pipeline Products by Development Stage
- Ellume Ltd Pipeline Products Summary by Development Stage
- Ellume Respirio Flu Test - Product Status
- Ellume Respirio Flu Test - Product Description
- ellume.lab - Influenza A+B / RSV - Product Status
- ellume.lab - Influenza A+B / RSV - Product Description
- ellume·lab - Product Status
- ellume·lab - Product Description
- ESP-Based Diagnostic Test - Chlamydia - Product Status
- ESP-Based Diagnostic Test - Chlamydia - Product Description
- ESP-Based Diagnostic Test - Gonorrhoea - Product Status
- ESP-Based Diagnostic Test - Gonorrhoea - Product Description
- ESP-Based Diagnostic Test - Group A Streptococci - Product Status
- ESP-Based Diagnostic Test - Group A Streptococci - Product Description
- ESP-Based Diagnostic Test - Malaria - Product Status
- ESP-Based Diagnostic Test - Malaria - Product Description
- ESP-Based Diagnostic Test - Pregnancy - Product Status
- ESP-Based Diagnostic Test - Pregnancy - Product Description
- Point of Care Flu-COVID Combination Diagnostic Test - Product Status
- Point of Care Flu-COVID Combination Diagnostic Test - Product Description
- Smart Phone Enabled Device - Product Status
- Smart Phone Enabled Device - Product Description
- Ellume Ltd, Key Employees
- Glossary
- Ellume Ltd Pipeline Products by Equipment Type
- Ellume Ltd Pipeline Products by Development Stage
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- ZiP Diagnostics Pty Ltd
- AusDiagnostics Pty Ltd
- Compumedics Ltd
